Alzheimer’s is the scourge of aging. But there is hope in an oral pharmaceutical from Alzheon. I interview Dr. Martin Tolar , Founder, CEO and President of Alzheon

Tolar

I interview Dr. Martin Tolar , Founder, CEO and President of Alzheon on the Phase 3 trial going on right now,  that will bring this drug up for FDA approval. We discuss how exercise, lifestyle and fasting can clear the brain, who will pay for breakthrough medications and how you can take your longevity into your hands and advocate for prevention of brain decline in our health system and in your own lifestyle. Let’s kick Alzheimer’s to the curb.